Cargando…

Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease

Unexplained weight changes that occur in Parkinson’s disease (PD), are often neglected and remain a poorly understood non-motor feature in patients with PD. A specific ‘Park-weight’ phenotype with low body weight has been described, and our aim was to evaluate the clinical and prognostic trajectorie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urso, Daniele, van Wamelen, Daniel J., Batzu, Lucia, Leta, Valentina, Staunton, Juliet, Pineda-Pardo, José A., Logroscino, Giancarlo, Sharma, Jagdish, Ray Chaudhuri, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345874/ https://www.ncbi.nlm.nih.gov/pubmed/35918350 http://dx.doi.org/10.1038/s41531-022-00362-3

Ejemplares similares

Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2021)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
por: Rota, Silvia, et al.
Publicado: (2022)

Magnetic Resonance Parkinsonism Index Is Associated with REM Sleep Behavior Disorder in Parkinson’s Disease
por: Urso, Daniele, et al.
Publicado: (2022)

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022)

Non-Motor Symptoms in Cervical Dystonia: A Concept in Evolution
por: Urso, Daniele, et al.
Publicado: (2020)

Treatment paradigms in Parkinson's Disease and Covid-19
por: Boura, Iro, et al.
Publicado: (2022)

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023)

Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
por: Metta, Vinod, et al.
Publicado: (2021)

Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
por: van Wamelen, Daniel J., et al.
Publicado: (2020)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies
por: Raeder, Vanessa, et al.
Publicado: (2023)

Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?
por: Urso, Daniele, et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis—The Complex Phenotype—From an Epidemiological Perspective: A Focus on Extrapyramidal and Non-Motor Features
por: Urso, Daniele, et al.
Publicado: (2022)

Grey-matter correlates of empathy in 4-Repeat Tauopathies
por: Tafuri, Benedetta, et al.
Publicado: (2023)

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
por: van Wamelen, Daniel J., et al.
Publicado: (2018)

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Descriptive Epidemiology of Neurodegenerative Diseases: What Are the Critical Questions?
por: Logroscino, Giancarlo, et al.
Publicado: (2022)

The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas
por: Logroscino, Giancarlo, et al.
Publicado: (2022)

Radiomics Model for Frontotemporal Dementia Diagnosis Using T1-Weighted MRI
por: Tafuri, Benedetta, et al.
Publicado: (2022)

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
por: Sportelli, Carolina, et al.
Publicado: (2020)

Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
por: Leta, Valentina, et al.
Publicado: (2021)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders
por: Gnoni, Valentina, et al.
Publicado: (2023)

The Role of Early Life Environmental Risk Factors in Parkinson Disease: What Is the Evidence?
por: Logroscino, Giancarlo
Publicado: (2005)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Asymmetry of radiomics features in the white matter of patients with primary progressive aphasia
por: Tafuri, Benedetta, et al.
Publicado: (2023)

Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease
por: Daniele, Antonio, et al.
Publicado: (2016)

The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter study
por: Tafuri, Benedetta, et al.
Publicado: (2022)

Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19
por: Nicolardi, Martina, et al.
Publicado: (2022)

Self-reported periodontitis and C-reactive protein in Parkinson’s disease: a cross-sectional study of two American cohorts
por: Lyra, Patrícia, et al.
Publicado: (2022)

Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom
por: Rukavina, Katarina, et al.
Publicado: (2022)

Effects of safinamide on pain in patients with fluctuating Parkinson's disease
por: Grigoriou, Sotirios, et al.
Publicado: (2021)

Different patterns of spreading direction and motor neurons involvement in a cohort of limb‐onset amyotrophic lateral sclerosis patients from Southern Italy: Potential implication on disease course or progression?
por: Milella, Giammarco, et al.
Publicado: (2023)

Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review
por: Smilowska, Katarzyna, et al.
Publicado: (2021)

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
por: Boura, Iro, et al.
Publicado: (2023)

Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
por: Raeder, Vanessa, et al.
Publicado: (2021)

Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
por: Bhidayasiri, Roongroj, et al.
Publicado: (2022)

A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics
por: Pantaleo, Ester, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bh3unj5mmq7ika5ntmrltgna4r